Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy

Clinical Immunology

Volumn 93, Issue 1, 1999, Pages 24-33

  Chavan, Surendra J ^a   Tamma, Seetha L ^a   Kaplan, Mark ^b   Gersten, Merril ^c   Pahwa, Savita G ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c AGOURON PHARMACEUTICALS INC   (United States)

Author keywords

Apoptosis; FACS; HIV AIDS; Human; T lymphocytes

Indexed keywords

DIDANOSINE; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0032869708     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4770     Document Type: Article

References (57)

1. Ameisen J. C. From cell activation to cell depletion. The programmed cell death hypothesis of AIDS pathogenesis. Adv. Exp. Med. Biol. 374:1995;139-163.
2. Casella C. R., Finkel T. H. Mechanisms of lymphocyte killing by HIV. Curr. Opin. Hematol. 4:1997;24-31.
3. Chia W. K., Freedman J., Li X., Salit I., Kardish M., Read S. E. Programmed cell death induced by HIV type 1 antigen stimulation is associated with a decrease in cytotoxic T lymphocyte activity in advanced HIV type 1 infection. AIDS Res. Hum. Retroviruses. 11:1995;249-256.
4. Clerici M., Fusi M. L., Ruzzante S. Type 1 and type 2 cytokines in HIV infection - A possible role in apoptosis and disease progression [editorial]. Ann. Med. 29:1997;185-188.
5. Cotton M. F., Ikle D. N., Rapaport E. L., Marschner S., Tseng P. O., Kurrle R., Finkel T. H. Apoptosis of CD4+ and CD8+ T cells isolated immediately ex vivo correlates with disease severity in human immunodeficiency virus type 1 infection. Pediatr. Res. 42:1997;656-664.
6. Meyaard L., Miedema F. Immune dysregulation and CD4+ T cell loss in HIV-1 infection. Springer Semin. Immunopathol. 18:1997;285-303.
7. Meyaard L., Otto S. A., Hooibrink B., Miedema F. Quantitative analysis of CD4+ T cell function in the course of human immunodeficiency virus infection. Gradual decline of both naive and memory alloreactive T cells. J. Clin. Invest. 94:1994;1947-1952.
8. Pantaleo G., Graziosi C., Demarest J. F., Cohen O. J., Vaccarezza M., Gantt K., Muro-Cacho C., Fauci A. S. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol. Rev. 140:1994;105-130.
9. Cotton M. F., Cassella C., Rapaport E. L., Tseng P. O., Marschner S., Finkel T. H. Apoptosis in HIV-1 infection. Behring Inst. Mitt. 97:1996;220-231.
10. Famularo G., De Simone C., Marcellini S. Apoptosis: Mechanisms and relation to AIDS. Med. Hypotheses. 48:1997;423-429.
11. Finkel T. H., Tudor-Williams G., Banda N. K. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1:1995;129-134.
12. Finkel T. H., Banda N. K. Indirect mechanisms of HIV pathogenesis: How does HIV kill T cells. Curr. Opin. Immunol. 6:1994;605-615.
13. Frost S. D., Michie C. A. Lymphocyte dynamics, apoptosis and HIV infection. Trends Microbiol. 4:1996;77-82.
14. Lu W., Andrieu J. M. Apoptosis and HIV disease. Nature Med. 1:1995;386-387.
15. Rothen M., Gratzl S., Hirsch H. H., Moroni C. Apoptosis in HIV-infected individuals is an early marker occurring independently of high viremia. AIDS Res. Hum. Retroviruses. 13:1997;771-779.
16. Meyaard L., Otto S. A., Jonker R. R., Mijnster M. J., Keet R. P., Miedema F. Programmed death of T cells in HIV-1 infection. Science. 257:1992;217-219.
17. Bohler T., Nedel S., Debatin K. M. CD95-induced apoptosis contributes to loss of primed/memory but not resting/naive T cells in children infected with human immunodeficiency virus type 1. Pediatr. Res. 41:1997;878-885.
18. Donnenberg A. D., Margolick J. B., Donnenberg V. S. Lymphopoiesis, apoptosis, and immune amnesia. Ann. N. Y. Acad. Sci. 770:1995;213-226.
19. Gougeon M. L., Lecoeur H., Dulioust A. Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J. Immunol. 156:1996;3509-3520.
20. Oyaizu N., McCloskey T. W., Than S., Hu R., Pahwa S. Mechanism of apoptosis in peripheral blood mononuclear cells of HIV-infected patients. Adv. Exp. Med. Biol. 374:1995;101-114.
21. Chirmule N., Pahwa S. Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol. Rev. 60:1996;386-406.
22. McCloskey T. W., Ott M., Tribble E. Dual role of HIV Tat in regulation of apoptosis in T cells. J. Immunol. 158:1997;1014-1019.
23. Stewart S. A., Poon B., Jowett J. B., Chen I. S. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71:1997;5579-5592.
24. Herbin G., Mahlknecht U., Batliwalla F., Gregersen P., Pappas T., Butler J., O'Brien W. A., Verdin E. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature. 395:1998;189-194.
25. Autran B., Carcelain G., Li T. S. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 277:1997;112-116.
26. Cavert W., Notermans D. W., Staskus K. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science. 276:1997;960-964.
27. Chun T. W., Stuyver L., Mizell S. B. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA. 94:1997;13193-13197.
28. Gulick R. M., Mellors J. W., Havlir D. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337:1997;734-739.
29. Hammer S. M., Squires K. E., Hughes M. D. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N. Engl. J. Med. 337:1997;725-733.
30. Pakker N. G., Notermans D. W., D. E. Bore R. J., Roos M. T. L., Wolf F. D., Hill A., Leonard J. M., Danner S. A., Miedema F., Schellekens P. T. A. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nature Med. 4:1998;208-214.
31. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
32. Zhang Z. Q., Notermans D. W., Sedgewick G., Cavert W., Wietgrefe S. W., Zupancic M., Gebhard K., Henry K., Boise L. H., Chen Z. Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc. Natl. Acad. Sci. USA. 95:1998;1154-1159.
33. Badley A. D., Dockrell D. H., Algeciras A., Ziesmer S., Landay A., Lederman M. M., Connick E., Kessler H., Kuritzkes D., Lynch D. H., Roche P., Yagita H., Paya C. V. In vivo analysis of Fas/FasL interactions in HIV-infected patients. J. Clin. Invest. 102:1998;79-87.
34. Hashimoto F., Oyaizu N., Kalyanaraman V. S., Pahwa S. Modulation of Bcl-2 protein by CD4 cross-linking: A possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2. Blood. 90:1997;745-753.
35. McCloskey T. W., Chavan S., Tamma S., Pahwa S. Comparison of seven quantitative assays to assess lymphocyte cell death during HIV infection: Measurement of induced apoptosis in anti-Fas-treated Jurkat cells and sponteneous apoptosis in peripheral blood mononuclear cells from children infected with HIV. AIDS Res. Hum. Retroviruses. 14:1998;1413-1418.
36. Gaddis M. L., Gaddis G. M. Intorduction to biostatistics: Part 6, Correlation and regression. Ann. Emerg. Med. 19:1990;1462-1468.
37. Eyster M. E., Ballard J. O., Gail M. H., Drummond J. E., Goedert J. J. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: Persistence of p24 antigen and low T4 cell count. Ann. Intern. Med. 110:1989;963-969.
38. Blair P. J., Boise L. H., Perfetto S. P. Impaired induction of the apoptosis-protective protein Bcl-xL in activated PBMC from asymptomatic HIV-infected individuals. J. Clin. Immunol. 17:1997;234-246.
39. Badley A. D., McElhinny J. A., Leibson P. J., Lynch D. H., Alderson M. R., Paya C. V. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:1996;199-206.
40. Carbonari M., Pesce A. M., Cibati M. Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy. Blood. 90:1997;209-216.
41. Markowitz M. H. HIV Pathogenesis and viral dynamics. Antiviral Ther. 2:1997;7-17.
42. Karmochkine M., Parizopt C., Calvez V., Coutellier A., Herson S., Debre P., Gorochov G. Susceptibility of peripheral blood mononuclear cells to apoptosis is correlated to plasma HIV load. J. Acquired Immune Defic. Syndr. Hum. Retroviruses. 17:1998;419-422.
43. Aries S., Weyrich K., Schaaf B., Hansen F., Dennin R., Dalhoff K. Early T-cell apoptosis and Fas expression during antiretroviral therapy in individual infected with human immunodeficiency virus-1. Scand. J. Immunol. 48:1998;86-91.
44. Johnson N., Parkin J. Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis. Clin. Exp. Immunol. 113:1998;229-232.
45. McCloskey T. W., Bakshi S., Than S., Arman P., Pahwa S. Immunophenotypic analysis of peripheral blood mononuclear cells undergoing in vitro apoptosis after isolation from human immunodeficiency virus-infected children. Blood. 92:1998;4230-4233.
46. Cohen J. Failure isn't what it used to be ... but neither is success. Science. 279:1998;1133.
47. Kaufmann D., Pntaleo G., Sudre P., Telenti A. for the Swiss HIV Chorot Study, CD4-cell count in HIV-1-infected individuals remaining virameic with highly active antiretroviral therapy (HAART). Lancet. 351:1998;723-725.
48. Levitz S. Improvement in CD4+ cell counts despite persistently detectble HIV load. N. Engl. J. Med. 338:1998;1074.
49. Marie-Lise G., Herve L., Yuko S. Apoptosis and the CD95 system in HIV disease: Impact of highly active anti-retroviral therapy (HAART). Immunol. Lett. 66:1999;97-103.
50. Badley A. D., Dockrell D., Simpson M., Schut R., Lynch D. H., Leibson P., Paya C. V. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185:1997;55-64.
51. Bohler T., Herr I., Debatin K. M., Geiss M., Haas J., Yang Y., Ashwell J. D. Downregulation of increased CD95 (APO-1/Fas) ligand in T cells from human immunodeficiency virus-type 1-infected children after antiretroviral therapy. Blood. 90:1997;886-887.
52. Boudet F., Lecoeur H., Gougeon M. L. Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection. J. Immunol. 156:1996;2282-2293.
53. Glynn J. M., McElligott D. L., Mosier D. E. Apoptosis induced by HIV infection in H9 T cells is blocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist. J. Immunol. 157:1996;2754-2758.
54. Katsikis P. D., Garcia-Ojeda M. E., Torres-Roca J. F., Tijoe I. M., Smith C. A., Herzenberg L. A. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. J. Exp. Med. 186:1997;1365-1372.
55. Oyaizu N., McCloskey T. W., Than S., Pahwa S. Inhibition of CD4 cross-linking-induced lymphocytes apoptosis by vesnarinone as a novel immunomodulating agent: Vesnarinone inhibits Fas expression and apoptosis by blocking cytokine secretion. Blood. 87:1996;2361-2368.
56. Oyaizu N., McCloskey T. W., Than S., Hu R., Kalyanaraman V. S., Pahwa S. Cross-linking CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon gamma and tumor necrosis factor-alpha secretion. Blood. 84:1994;2622-2626.
57. McCloskey T. W., Oyaizu N., Kaplan M., Pahwa S. Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry. 22:1995;111-114.